Transgenic mice that overexpress cyclooxygenase-2 (COX-2) selectively in podocytes are more susceptible to glomerular injury by adriamycin and puromycin (PAN). To investigate the potential roles of COX-2 metabolites, we studied mice with selective deletion of prostanoid receptors and generated conditionally immortalized podocyte lines from mice with either COX-2 deletion or overexpression. Podocytes that overexpressed COX-2 were virtually indistinguishable from wild-type podocytes but were significantly more sensitive to PAN-induced injury, produced more prostaglandin E 2 and thromboxane B 2 , and had greater expression of prostaglandin E 2 receptor subtype 4 (EP 4 ) and thromboxane receptor (TP). Treatment of COX-2-overexpressing podocytes with a TP antagonist reduced apoptosis, but treatment with an EP 4 antagonist did not. In contrast, podocytes from COX-2-knockout mice exhibited increased apoptosis, markedly decreased cell adhesion, and prominent stress fibers. In vivo, selective deletion of podocyte EP 4 did not alter the increased sensitivity to adriamycin-induced injury observed in mice overexpressing podocyte COX-2. In contrast, genetic deletion of TP in these mice prevented adriamycin-induced injury, with attenuated albuminuria and foot process effacement. These results suggest that basal COX-2 may be important for podocyte survival, but overexpression of podocyte COX-2 increases susceptibility to podocyte injury, which is mediated, in part, by activation of the thromboxane receptor. 20: 195320: -196220: , 200920: . doi: 10.1681 Podocytes play a crucial role in regulation of glomerular function, and podocyte injury is an essential feature of progressive glomerular diseases. Although our understanding of podocyte biology has dramatically increased in recent years, mechanisms underlying functional and structural podocyte disturbances in renal diseases are still incompletely understood. 1 Recent studies indicate that local podocyte damage can spread to induce injury in otherwise healthy podocytes and further affect both glomerular endothelial and mesangial cells, implying that even limited podocyte injury might initiate a vicious cycle of progressive glomerular damage. 2 Mice with cyclooxygenase-2 (COX-2) gene deletion exhibit impaired glomerulogenesis and renal cortical development. 3 However, increased expression of COX-2 in podocytes has been reported in various experimental models of progressive glomerular injury 4,5 and in cultured podocytes stimulated by mechanical stress. 6 Furthermore, in models of renal ablation, diabetic nephropathy, and salt-
Podocytes play a crucial role in regulation of glomerular function, and podocyte injury is an essential feature of progressive glomerular diseases. Although our understanding of podocyte biology has dramatically increased in recent years, mechanisms underlying functional and structural podocyte disturbances in renal diseases are still incompletely understood. 1 Recent studies indicate that local podocyte damage can spread to induce injury in otherwise healthy podocytes and further affect both glomerular endothelial and mesangial cells, implying that even limited podocyte injury might initiate a vicious cycle of progressive glomerular damage. 2 Mice with cyclooxygenase-2 (COX-2) gene deletion exhibit impaired glomerulogenesis and renal cortical development. 3 However, increased expression of COX-2 in podocytes has been reported in various experimental models of progressive glomerular injury 4, 5 and in cultured podocytes stimulated by mechanical stress. 6 Furthermore, in models of renal ablation, diabetic nephropathy, and salt-sensitive hypertension, inhibition of COX-2 activity by selective COX-2 inhibitors significantly decreases proteinuria and progressive renal injury. [7] [8] [9] [10] [11] To determine if increased podocyte COX-2 expression plays a pathogenic role in glomerular injury, we recently generated COX-2 transgenic mice driven by a nephrin promoter, successfully inducing selective upregulation of COX-2 expression in podocytes. Although glomerular structure and function were normal at baseline in these transgenic mice, administration of either adriamycin or puromycin (PAN) led to significantly increased albuminuria compared with wildtype mice and induced further upregulation of COX-2 and downregulation of the slit diaphragm molecule nephrin. These studies suggested that increased podocyte COX-2 in response to injury may predispose the podocyte to further injury. 12, 13 In cultured podocytes, mechanical stress induced COX-2 and expression of the prostaglandin E 2 (PGE 2 ) receptor subtype 4 (EP 4 ), and PGE 2 stimulation of stretched podocytes resulted in a loss of actin stress fiber organization. 6 These results suggest that enhanced prostanoid signaling may be a facilitating event for morphologic changes and may directly influence podocyte function under pathophysiological conditions that promote synthesis of COX-2 metabolites. To investigate potential roles of COX-2 metabolites in podocyte function, we generated conditionally immortalized podocyte lines with either deficiency or overexpression of COX-2. In further in vitro and in vivo studies, we identified a role for COX-2-derived prostanoids as potential mediators of podocyte injury.
RESULTS

Activation of Podocyte Prostaglandin Production in Response to Injury
To investigate the potential role of prostanoids in podocyte injury, we generated conditionally immortalized cultured podocytes from wild-type mice and mice with increased podocyte COX-2 expression (podCOX-2-tg). Immunoreactive COX-2 expression is indicated in Figure 1A . As expected, the podocytes from podCOX-2-tg mice exhibited a high basal level of immunoreactive COX-2, whereas a low level of expression was detectable in podocytes from wild-type mice. We previously showed that podCOX-2-tg mice exhibited significantly increased glomerular injury in response to adriamycin. To determine the prostanoid receptor(s) that might be involved in this podocyte injury response, we initially determined prostanoid receptor mRNA expression in cultured wild-type mouse podocytes. In agreement with previous findings, 14 cultured wild-type podocytes expressed mRNA for the PGE 2 receptor subtypes EP 1 and EP 4 , the thromboxane A 2 receptor (TP), and the prostaglandin F 2␣ (PGF 2␣ ) receptor (FP), but did not express detectable EP 2 , EP 3 , or prostacyclin (intraperitoneally) receptor mRNA ( Figure 1B ). Similar to wild-type podocytes, podCOX-2-tg podocytes also expressed only EP 1 and EP 4 , TP, and FP. We exposed cells to PAN (50 g/ml) for 24 h and measured production of PGE 2 , prostacyclin (6-keto-PGF 1␣ ), and thromboxane B 2 (TxB 2 ) in PAN-treated podCOX-2-tg and wildtype podocytes. In podCOX-2-tg podocytes, PAN significantly increased PGE 2 production (fourfold basal levels, P Ͻ 0.05) and TxB 2 production (2.4-fold basal levels, P Ͻ 0.05) but only minimally increased prostacyclin production (1.2-fold basal levels, NS) ( Figure 2 ). In podocytes from wild-type mice, PAN also stimulated TxB 2 production (threefold basal levels, P Ͻ 0.05).
Puromycin induced EP 4 and TP mRNA expression in the podCOX-2-tg podocytes but not in wild-type podocytes (2.3 Ϯ 0.4 versus 1.1 Ϯ 0.3 and 2.9 Ϯ 0.3 versus 1.3 Ϯ 0.2 fold control, respectively, n ϭ 4, P Ͻ 0.05 compared with wild-type and podCOX-2-tg basal levels or wild type ϩ PAN), whereas EP 1 and FP mRNA levels did not increase ( Figure 3A) . Similarly, protein levels of EP 4 and TP increased in the PAN-treated podCOX-2-tg podocytes ( Figure 3B ).
Prostanoid receptor mRNA and protein expression also were determined in glomeruli isolated from wild-type and podCOX-2-tg mice under basal conditions or 6 wk after administration of adriamycin. mRNA levels of EP 4 and TP increased significantly in glomeruli isolated from adriamycin-treated podCOX-2-tg mice (3.3 Ϯ 0.2 and 3.0 Ϯ 0.1 fold control of podCOX-2-tg, n ϭ 4, P Ͻ 0.05 compared with basal levels of wild type, podCOX-2-tg, or wild type ϩ adriamycin) ( Figure 3C ). Protein levels of EP 4 and TP also increased in glomeruli from podCOX-2-tg mice in response to adriamycin ( Figure 3D ).
Effect of TP or EP 4 Receptor Deletion on AdriamycinInduced Podocyte Injury in podCOX-2-tg Mice
We have demonstrated previously that the increased adriamycin-induced glomerular injury seen in podCOX-2-tg mice was prevented by a selective COX-2 inhibitor. 12 To determine whether the alterations in podocyte structure and function seen in vivo were due to alterations in either EP 4 Figure 4A ).
There were no apparent structural abnormalities detectable by light or electron microscopy or increased albuminuria at baseline in podCOX-2-tg mice with either TP deletion or podocyte EP 4 deletion. In response to adriamycin, podCOX-2-tg x EP 4 podocyteϪ/Ϫ mice exhibited comparable increases to podCOX-2-tg mice in albuminuria, which began to increase by 2 wk (Supplemental Figure 1) and had similar levels of albuminuria at 6 wk (50.4 Ϯ 7.0 versus 55.0 Ϯ 11.7 g albumin (Alb)/mg creatinine, NS) ( Figure  4B ) and structural glomerular abnormalities (moderate mesangial sclerosis and foot process effacement, 54.0 Ϯ 1.8% versus 56.7 Ϯ 7.9%, NS) ( Figure 4C ). In contrast, in response to adriamycin, podCOX-2-tg x T Ϫ/Ϫ mice had significantly less albuminuria (26.8 Ϯ 4.8 g Alb/mg creatinine, n ϭ 6, P Ͻ 0.05) ( Figure 4B ) and foot process effacement (15.0 Ϯ 1.7%, P Ͻ 0.05) ( Figure 4C ), although no significant differences were detectable by light microscopy.
Pathologic Impact of COX-2 Overexpression in PANInduced Podocyte Injury
There were no apparent differences in basal attachment spreading and survival of podCOX-2-tg podocytes compared with those of wild-type podocytes ( Figure 6A ). However, PAN induced significantly more apoptosis in podCOX-2-tg podocytes than in wild-type podocytes ( Figure 5A ), although cytoskeleton reorganization was observed in both cell types (Figure 5B ). L-161982, a specific EP 4 receptor antagonist, did not significantly decrease apoptosis in response to PAN administration ( Figure 5C ). In contrast, the TP antagonist SQ29548 significantly reduced PAN-induced apoptosis (from 47.8 Ϯ 5.1% to 28.0 Ϯ 4.4%, n ϭ 4, P Ͻ 0.05) ( Figure 5C ).
Impact of Exogenous PGE 2 and Thromboxane Analogues on Cultured Podocytes
Prostaglandin E 2 has been reported to promote podocyte cytoskeleton disorder induced in response to mechanical stretching. 6 However, when exogenous PGE 2 was administered to wild-type podocytes 10 min before PAN, there was no change in the amount of apoptosis ( Figure 6A ). In contrast, a thromboxane A 2 (TxA 2 ) analogue, U-46619, significantly increased PAN-induced podocyte apoptosis, which could be inhibited by the TP receptor antagonist SQ29548 ( Figure 6B ).
Effect of COX-2 Deletion in Podocytes
We also developed conditionally immortalized podocyte cell lines from COX-2 Ϫ/Ϫ mice. As expected, these podocytes expressed no immunoreactive COX-2 ( Figure 1A ). The COX-2-knockout podocytes had markedly decreased cell adhesion to type IV collagen ( Figure 7A ) and laminin (data not shown). When grown on glass coverslips, the COX-2-knockout podocytes demonstrated cytoskeleton disorganization and displayed prominent cortical actin rings ( Figure 7B ). Furthermore, they had an increased basal rate of apoptosis (65.3 Ϯ 5.9% in COX-2-knockout mice versus 1.0 Ϯ 0.4% in wild-type mice, P Ͻ 0.05) ( Figure 7C ). Puromycin administration resulted in virtually complete detachment of COX-2-knockout podocytes. . Puromycin-induced production of (top) PGE 2 , (middle) PGF 1␣ , and (bottom) TxB 2 in podocytes from podCOX-2-tg mice. Differentiated podocytes were cultured as described in Concise Methods. Puromycin (50 g/ml) was added to wild-type and podCOX-2-tg podocytes 24 h before the measurement of prostaglandin production. Results were normalized to total cellular protein content (n ϭ 4; *P Ͻ 0.05 compared with basal level; #P Ͻ 0.05, between wild type ϩ PAN and podCOX-2-tg ϩ PAN).
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DISCUSSION
Cyclooxygenases are rate-limiting enzymes that metabolize arachidonic acid to prostaglandin G 2 and subsequently to prostaglandin H 2 . Prostaglandin H 2 then serves as a common substrate for further synthesis of specific prostanoids (prostaglandins and thromboxane) by specific synthases. Prostaglandins mediate many important physiologic processes, such as regulation of vascular tone, salt and water homeostasis, and mediation or modulation of hormonal actions. Unlike the constitutive isoform COX-1, expression and activity of COX-2 are induced in response to a variety of stimuli, and COX-2 metabolites mediate inflammation and pain. Prostanoids are bioactive lipids that exert autocrine and paracrine functions by binding to specific G-protein-coupled receptors to activate intracellular signaling and gene transcription. Of note, PGE 2 can interact with four G-protein-coupled receptor subtypes: EP 1 , EP 2 , EP 3 , and EP 4 . Of interest for the present studies, EP 1 is coupled to G q and is a vasoconstrictor, whereas EP 4 is coupled to G s and induces vasodilation. PGF 2␣ and TxA 2 are also G q -coupled receptors that induce increases in intracellular calcium and vasoconstriction. Of note, thromboxane receptors are activated not only by TxA 2 but also by the common prostanoid precursor prostaglandin H 2 .
COX-2 expression increases in podocytes in response to a variety of glomerular injuries, 4, 5 and our previous studies demonstrated that increased podocyte COX-2 expression predisposes to further podocyte injury in response to adriamycin or PAN. 12 In the present studies, we found that adriamycin selectivity increased glomerular expression of the PGE 2 receptor subtype EP 4 and the thromboxane receptor TP. When we crossed the podocyte COX-2-overexpressing mice to TP knockout mice, the increased sensitivity to adriamycin injury was reversed, whereas podCOX-2-tg mice with selective podocyte EP 4 deletion were not protected.
We also generated cultured podocytes from wild-type and podCOX-2-tg mice and found that, similar to the in vivo observations, PAN administration increased PGE 2 and thromboxane production and EP 4 and TP expression in podCOX-2-tg podocytes. We also found that PAN-induced apoptosis in pod-COX-2-tg podocytes was significantly decreased by a TP receptor antagonist but not by an EP 4 receptor antagonist. Similarly, in wild-type podocytes, administration of a thromboxane analogue augmented PAN-induced apoptosis, whereas PGE 2 administration had no effect. Therefore, these results suggest that podocyte injury may induce COX-2 expression and increase thromboxane production, which then sensitizes the podocyte to further injury. Previous studies in cultured podocytes indicated that mechanical stress induced increased COX-2-derived PGE 2 production and alterations in the cytoskeleton. 6 In preliminary studies, we did detect that podocyte adhesion was inhibited by PGE 2 administration, which was reversed by the EP 4 antagonist (data not shown). Recently, PGE 2 was reported to initiate a positive feedback loop via EP 4 in the podocyte signaling network, activated by increased glomerular capillary pressure, which could be detrimental to podocyte health and glomerular filtration barrier integrity. 17 However, other studies have suggested that PGE 2 serves a cytoprotective function in renal epithelial cells 18, 19 In other cell types, PGE 2 has been shown to promote cell survival, cell growth, migration, invasion, and angiogenesis. 20, 21 In this regard, podocytes from COX-2-knockout mice were found to exhibit significant apoptosis even under basal conditions, suggesting that COX-2-derived prostaglandins also may serve a trophic cytoprotective function. Although selective COX-2 inhibitors have been shown to decrease proteinuria and retard progressive glomerular injury in experimental models of kidney disease, 22 the associated cardiovascular risks preclude the therapeutic use of COX-2 inhibitors in progressive renal injury. Thromboxane A 2 and thromboxane receptor activation mediate renal vasoconstriction and contribute to the pathogenesis of angiotensin-IIdependent hypertension, 23 progression of diabetic nephropathy, 24 -27 and renal failure in endotoxemic mice 28 or rats with 5/6 nephrectomy. 29 Older studies suggested that thromboxane synthase inhibitors or receptor antagonists were efficacious in streptozotocin-induced renal damage, 30 lupus nephritis, [31] [32] [33] cyclosporine nephrotoxicity, 34 -36 remnant kidney, 37 and renal allograft rejection. 38 Our current results strongly suggest that thromboxane receptor antagonism may serve as a viable potential therapeutic option to retard podocyte injury.
In summary, these studies indicate that COX-2 and its derived prostaglandins may mediate basal podocyte differentiation and survival, at least in vitro. Although increased podocyte COX-2 concentrations do not significantly affect basal physiologic function in response to renal insults, increased podocyte COX-2 expression does contribute to susceptibility to further injury, at least in part through increased thromboxane production and increased thromboxane receptor expression.
CONCISE METHODS
Materials
Puromycin was purchased from Sigma Chemical (St. Louis, MO). Adriamycin was from Bedford Laboratories (Belford, OH). SC58236 was a gift from Pfizer (St. Louis, MO). The EP 4 receptor antagonist L-161982 was a generous gift from Dr. John Obenchain (Merck Frosst Canada & Co., Kirkland, Quebec, Canada). The rabbit anti-murine COX-2 polyclonal antibody, PGE 2 , 6-keto-PGF 1␣ , TxB 2 enzyme immunoassay kits, specific TP receptor antagonist SQ29548, TxA 2 analogue-U-46619, PGE 2 , specific EP 1 receptor antagonist SC19920, and rabbit anti-EP 1 , EP 4 , FP, and TP polyclonal antibodies were purchased from Cayman Chemical (Ann Arbor, MI); goat antinephrin, rabbit anti-synaptopodin, and goat anti-actin antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Fluorescence phallotoxin was from Molecular Probes/Invitrogen Detection Technologies (Eugene, OR), terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling apoptosis detection kit was from Upstate (Lake Placid, NY), and Dynabeads M-450 Tosylactivated BASIC RESEARCH www.jasn.org were purchased from Dynal Biotec (Lake Success, NY). Nylon cell strainers were purchased from BD Biosciences (Bedford, MA). Albuwell and creatinine kits were from Exocell (Philiadaphia, PA). Other reagents were purchased from Sigma Chemical (St. Louis, MO).
Experimental Animals
Nephrin-driven COX-2 transgenic mice on the B6/D2 background (podCOX-2-tg) were genotyped by PCR and Southern blotting as described previously. 12 The EP 4 flox/flox mice 39 generated a podocyte-selective EP 4 deletion (EP 4 podocyteϪ/Ϫ ) after Cre-dependent excision by breeding to podocin-specific Cre mice, which were from Susan Quaggin 40, 41 Both thromboxane-receptor-deficient mice (TP Ϫ/Ϫ ) (on a B6/D2 background) 42 and EP 4 podocyteϪ/Ϫ mice (on a C57/B6 background) were further bred to podCOX-2-tg mice. Both B6/D2 12 and C57/B6 43 mice are resistant to adriamycin-induced renal injury.
To determine glomerular injury in response to adriamycin, ageand strain-matched (10-to 12-wk-old) male mice were administered adriamycin (10 mg/kg by retroorbital injection) or saline as controls. Urine was collected weekly in metabolic cages, and the mice were euthanized at the end of 6 wk. Glomerular injury was assessed histologically by light microscopy and electron microscopy.
All animal procedures were approved by the Animal Care and Use Committee of Vanderbilt University Medical Center.
Isolation of Glomeruli
Glomeruli were isolated immediately after euthanasia, using a modification of the Dynabeads method of Takemoto et al. 44 Briefly, mice were anesthetized by an intraperitoneal injection of Nembutal (0.05 mg/g body wt) and perfused through the descending aorta with 8 ϫ 10 7 Dynabeads (Dynal Biotech, ASA, Oslo, Norway) diluted in PBS. The kidneys were removed, minced into 1-mm 3 pieces, and digested in collagenase (1 mg/ml collagenase A and 100 U/ml deoxyribonuclease I in HBSS) at 37°C for 30 min with gentle agitation. The collagenase-digested tissue was gently pressed through a 100-m cell strainer using a flattened pestle, and the cell strainer was then washed with 5 ml of cold HBSS. The filtered cells were passed through a new cell strainer without pressing, and the cell strainer was washed with 5 ml of cold HBSS. The cell suspension was then centrifuged at 200 ϫ g for 5 min at 4°C. The supernatant was discarded, and the cell pellet was resuspended in 2 ml of cold HBSS. Finally, glomeruli containing Dynabeads were gathered by a magnetic particle concentrator and washed three times with cold HBSS. During the procedure, kidney tissues were kept at 4°C except for the collagenase digestion at 37°C. The preparation consisted of Ͼ90% glomeruli.
Culture of Mouse Podocytes
To generate immortal podocyte cell lines, the COX-2-knockout mice 3 or podCOX-2-tg mice were bred to ImmortoMouse (Charles River, Wilmington, MA), and only mice expressing both the SV40 gene and either COX-2 deficiency or increased podocyte COX-2 expression were selected. Primers used for genotyping are summarized in Table 1 .
Conditionally immortalized mouse podocyte cells were generated as described previously. 45, 46 Briefly, epithelial cells from decapsulated glomeruli were isolated and grown at high density in RPMI 1640 ϩ 10% FCS. After 5 to 7 d, the cultures were slightly trypsinized to remove glomerular remnants and immunodissected with an antinephrin antibody. Podocytes were maintained in the medium with mouse recombinant IFN-␥ (Sigma, St. Louis, MO) (with gradually reduced concentrations from 100 to 10 U/ml) for permissive conditions (33°C). Dishes were coated with type I collagen (Sigma, St. Louis, MO), and cells were plated at a density of 1 ϫ 10 5 cells/cm 2 . Podocytes were cloned and characterized by specific markers (e.g., nephrin and Wilms Tumor 1 for podocytes and synaptopodin for differentiated podocytes). Cells between passage 10 and 15 were used for all experiments. Differentiation was induced by switching the incubation temperature to 37°C (nonpermissive conditions) and removing IFN-␥ from the culture media for 10 to 14 d.
RNA Extraction and Real-Time RT-PCR
Total glomerular and podocyte RNA were extracted using TRI Reagent (Molecular Research Center, Cincinnati, OH) and chloroform and further purified with an RNeasy kit (Qiagen, Valencia, CA). Real-time RT-PCR was performed with specific primers (Table 2) and IQ SYBR Green Supermix Kit (Bio-Rad Laboratories, Hercules, CA) at 95°C for 3 min and then 95°C for 20 s, 62°C for 20 s, and 72°C for 60 s in 40 cycles. Glyceraldehyde 3-phosphate dehydrogenase was used as an internal control. Comparative C T and statistical analysis were calculated as per instructions of User Bulletin #2 from ABI (Applied Biosystems, Hammonton, NJ).
Immunoblotting
Cultured cells or isolated glomeruli were homogenized as described previously. 47 Proteins were resuspended in SDS sample buffer, diluted in SDS buffer containing 2-mercaptoethanol (Sigma Chemical, St. Louis, MO), and boiled for 10 min before loading. The samples were run on 8% SDS-PAGE gels under reducing conditions and transferred onto a polyvinylidene fluoride membrane (Immobilion-P; Millipore, Bedford, MA). After (A) COX-2 deletion led to the detachment of differentiated podocytes. Adhesion to collagen IV was measured as described in Concise Methods (n ϭ 4; *P Ͻ 0.05 compared with wild type or COX-2 transgenic group). There was no significant difference between these two groups. (B) COX-2 deletion increased basal podocyte apoptosis. Green (FITC) staining indicated the cell apoptosis in the top panel; blue (4Ј,6-diamidino-2-phenylindole) staining indicated the total podocytes. (C) COX-2 deletion led to disruption of the normal podocyte actin cytoskeleton. Actin filaments were stained by phalloidin binding assay. In COX-2-knockout podocytes, the stress fibers could be easily appreciated; some cells displayed a prominent cortical actin ring.
BASIC RESEARCH www.jasn.org being blocked with 5% nonfat milk in Tween®/Tris-buffered salt solution, the membranes were exposed to the primary antibody overnight at 4°C, followed by horseradish-peroxidase-conjugated secondary antibodies. The horseradish peroxidase signal was enhanced using the europium-sensitized luminescence method, and the images were developed on high-performance autoradiography film (Hyperfilm MP; Amersham Biosciences, Buckinghamshire, UK). Membranes were rehybridized with goat anti-␤-actin antibody (Santa Cruz, CA) to normalize protein loading.
Phallodin Binding Assay
Cultured differentiated podocytes on glass coverslips were washed in PBS, fixed in 3.7% paraformaldehyde in PBS for 20 min, and extracted with acetone at Ϫ20°C for 3 to 5 min. After being blocked with 1% BSA, podocytes were incubated with 0.1% saponin in PBS containing a saturating amount (0.4 M) of Oregon Green 488 phalloidin (Invitrogen Corporation, Carlsbad, CA) for 30 min at room temperature in darkness and examined at 500 to 520 nm.
Cell Adhesion Assay
We utilized modifications of a previously described protocol. 48 Briefly, 100 l of single-cell podocyte suspensions (1 ϫ 10 6 cells/ml) in serum-free medium containing 0.1% BSA were added to 96-well plates coated with collagen IV or laminin and blocked with 0.1% BSA, followed by incubation for 60 min at 37°C. Nonadherent cells were removed by washing the wells with PBS. Cells were then fixed with 4% paraformaldehyde and stained with 1% crystal violet, and the OD of the cell lysates was read at 570 nm. Cells bound to wells coated with 100% FCS were used to indicate 100% adhesion (control), and cells bound to wells coated with 1% BSA were used to evaluate background. Each sample was performed in triplicate and expressed as fold of control. Because the data for adhesion to collagen IV and laminin produced similar results, we only show the former in this paper.
Apoptosis Detection
Measurements utilized a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling apoptosis detection kit (Upstate, Lake Placid, NY). 4Ј,6-Diamidino-2-phenylindole was used for counterstain. The percentage of apoptotic cells in 400 total cells from the same field was determined for quantification.
Urinary Albumin and Creatinine
Urinary albumin levels were determined by ELISA using a murine microalbuminuria ELISA kit (AlbuwellM; Exocell, Philadelphia, PA). The urine creatinine concentration was measured with a microplate assay kit (Creatinine Companion; Exocell, Philadelphia, PA). All measurements were performed in duplicate, and albuminuria was determined as the ratio of urinary albumin (g/ml) to creatinine (mg/ ml).
Statistical Analysis
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